RG7314

· Hoffmann-La Roche

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for RG7314, covering 2016-07-04 to 2017-02-03. Get the full timeline:

Most recent: Clinical Trial Update: A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD) [Phase 2]

See pricing